Loading clinical trials...

Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology | Clinical Trials | Clareo Health

COMPLETEDNA

Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology

Immediate Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology

NCT04369339•Bezmialem Vakif University

View on ClinicalTrials.gov

Summary

Abnormal cervical cytology was the most common reason for women being referred to the colposcopy unit. We prospectively included the women with negative cytology (negative for intraepithelial lesions or malignancy (NILM)) and positive High RiskHPV test other than HPV 16 or HPV 18. Comparing the immediate colposcopy findings among women with High Risk HPV other than HVPV16/18 and negative cytology and determine positive predictive values for CIN2+ of other high risk HPV genotypes

Eligibility

Age

18 - 65 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•negative cytology (negative for intraepithelial lesions or malignancy (NILM)) and positive HrHPV test other than HPV 16 or HPV 18

Exclusion Criteria

•Previous diagnosis for cervical cancer Previous diagnosis for vaginal cancer Previous diagnosis for cervical dysplasia Previous diagnosis for ASCUS previous history of cervical conisation or hysterectomy previous history ofhysterectomy

Key Dates

Start Date

June 1, 2015

Primary Completion Date

October 1, 2019

Completion Date

January 1, 2020

Last Updated

April 30, 2020

Enrollment

185

ACTUAL participants

Conditions

Human Papillomavirus Infection

Interventions

Colposcopy

OTHER

Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy

NCT05860725

Human Papillomavirus InfectionVaccination Hesitancy

View study

RECRUITING

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

NCT05918510

Squamous Cell Carcinoma of the OropharynxCarcinomas of Unknown Primary Site+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 30, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology

Inclusion Criteria

Exclusion Criteria

Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

Prospective Evaluation of Self-Testing to Increase Screening

Transmission of Oncogenic HPV Infection Among Families